Sanofi-Genzyme BioVentures

Suggest edits

Follow us

Also headquartered in Cambridge

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 14

Portfolio

Portfolio Tracker

Add info

Center City’s HealthVerity has acquired cloud-based drug rebate platform Curisium

$45,000,000 Venture capital (Series D)

Evidation Health: $45 Million Funding And Sam Marwaha Joins As Chief Commercial Officer

Evidation Health Raises $45M in Series D Funding

$46,000,000 Venture capital (Series A)

Q32 Bio Raises $46M in Series A Funding

Omada Health scores $57 million as coronavirus pandemic sparks investor interest in health tech

$4,000,000 Seed fund

i2O Therapeutics Raises $4m in Seed Funding

With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite

Undisclosed

Omada Health Receives Investment from Intermountain Ventures

Omada Health launches mental health programs using shuttered startup's tech

$30,000,000 Venture capital (Series C)

Evidation Health scores $30 mln Series C

Messaging

Evidation Health Raises $30M in Series C Venture Capital Funding

Health Funding Cloud

Omada Health expands into chronic disease management for diabetes, hypertension

Health Apps & Services

Science37 Seeks $130M More For Clinical Trial Technology

Funding

SoftBank is in talks to lead a $150 million investment in clinical trial startup Science 37

Robotics Funding Health

Science 37 Links With Pharmaceuticals Firm UCB

Funding Health

$69,200,000 IPO

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets

$14,000,000 Venture capital (Series A)

, ,

Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD work

NeuroVia Raises $14M to Test Drug for Rare, Fatal Metabolic Disease

Health Science

Index

By TNW